« Government Sets Rules for $1B in Therapeutic Discovery Credits or Grants | Main | Stop Picking on Genzyme! Slight Tip of the Cap for Lumizyme. »

05/26/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133ee9e010f970b

Listed below are links to weblogs that reference Developing Nations Won't Solve Big Pharma's Growth Troubles:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

Despite naysaying in my post above, Lilly is set to double its presence in emerging markets in the next several years & considers this key to its growth strategy.
http://online.wsj.com/article/SB10001424052748703303904575292651202910886.html?mod=rss_Health

bigredbruce

The emerging markets may not solve all Big Pharma problems bu tthat sure isn't preventing any mad rush to India.
http://seekingalpha.com/article/207310-big-pharma-eyes-india

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada